🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FDA-cleared dual-lumen endoscopic aspiration catheter, CleanCapture, debuts at #DDW2025 pushing the boundaries of innovation in microbione research. Current single-lumen catheters have unacceptable high contamination rates. ClearCapture is designed to change that.

We found that #SIBO is common in #celiac disease. 🦠17.6% at 10^5, 49.6% at 10^3, 23.1% on breath test 🦠even higher in refractory CD: 36.8% and 78.9% (aspirates) Come learn more TODAY 12:30-1:30 at session Mo1414! #MedTwitter #GITwitter

Today at 12:30, (Mo1405) Ali Rezaie MD MSc Gabriela Leite, PhD Ruchi Mathur MD and MAST Research Program present the second work on the massive 6000 patient nationwide three gas breath test study. Bloating is most common reason for test. Hydrogen sulfide is associated with more severe #diarrhea.

Incredible talk by Siew Ng on the evolution of IBD epidemiology and its links to the Western diet. Insightful data and a hopeful message that we may be able to reverse the clock! #DDW2025 Gil Kaplan MD MPH

Dr. Germano from MAST Research Program presents data showing that a palatable elemental diet reduces fecal archaeal load, with a direct correlation to daily breath methane levels in IMO. Therapeutic diet meets diagnostics. #DDW2025 #Microbiome

Very proud of our amazing GI Motility Fellow Nicha Wongjarupong who presented her anorectal research with Ali Rezaie MD MSc at the Digestive Disease Week! She is a future ⭐️ in Motility and will soon bring all her expertise to Thailand 🇹🇭!

Thanks @heliogastro for covering this story. Many exciting new developments in the #microbiome of #IBS are now coming. Low-dose rifaximin plus N-acetylcysteine superior to rifaximin alone in IBS-diarrhea healio.com/news/gastroent…

Head-to-head trial of tirzepatide vs semaglutide confirms what we see in clinic: tirzepatide has a better GI side effect profile. Semaglutide had higher discontinuation due to GI effects (5.6% vs 2.7%) and more GERD. nejm.org/doi/full/10.10…

📊 A clinical trial led by Ali Rezaie MD MSc and team Cedars-Sinai found that a palatable elemental diet relieved symptoms in 83% of patients with SIBO or IMO. A promising non-pharmacologic approach to managing these challenging GI disorders. #SIBO #IBS bit.ly/4kwN7KG

This hits hard! Defining disorders affecting >20% of the population based on nonspecific symptoms, w/o pathophysiologic anchors, keeps us trapped in a loop of noise and empiric Rx, not progress.

🚨 We're hiring! GI motility program Cedars-Sinai is looking for a Clinical Dietitian II to join our multi-disciplinary neurogastromotility team. Passionate about gut health, microbiome, nutrition, and trailblazing innovation? This role is for you. 🔗 careers.cshs.org/job/beverly-hi…

Delighted to present today at #AIC2025 "From fuel to function: Harnessing elemental diet for gut and microbiome"

nypost.com/2025/04/30/hea…

Now in press‼️🚨📢 Adding to the dialogue, the newest evidence-based consensus on perioperative management for patients taking GLP-1 RAs informed by a systematic review of clinical outcomes and gastric emptying data Proud to share that MAST endocrinologist Ruchi Mathur MD was a

Just recorded a fantastic podcast with Prof. Lucinda Harris (Mayo Clinic) and Prof. David Kunkle (UC San Diego) diving into the GI manifestations, diagnosis, and treatment of amyloidosis—one of the great masqueraders in medicine. Don't miss this one! Gi Health Foundation

Intricate study done by Singh and William Chey on interaction of gut microbiome, food, mast cells and gut barrier function. Great presentation by Kate Scarlata, MPH, RDN at GIHF in Denver

Excited to share highlights from top neurogastromotility studies at #DDW2025 during the SoCal GI Conference in Huntington Beach: 1️⃣ Rifaximin + NAC shows promise in IBS-D 2️⃣ Palatable elemental diet lowers gut methanogens 3️⃣ High SIBO prevalence in celiac disease 4️⃣ GLP-1s alter

#CGH4ALL 📣 💨 Excess methane = Constipation ↑,💩 Diarrhea↓ ➡️ Interesting implications for microbiome research! 🧠 This meta-analysis breaks down the GI symptom profile in IMO. 📲 Read more in CGH 🖇️ doi.org/10.1016/j.cgh.… Reported by Ariana Pereira Sepideh Mehravar, MD

Our Advanced GI Motility Fellow, Nicha Wongjarupong just graduated, and we couldn’t be prouder! She’s heading to one of Thailand’s leading hospitals to help advance the field of neurogastromotility. A big win for global GI care!

Nicha Wongjarupong is making her #Country #Thailand #Motility #mentors #parents all so proud!! ANMS Ali Rezaie MD MSc IFFGD 🎉❤️How lucky for patients too